Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in MDD with Painful Physical Symptoms
NCT01070329Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of duloxetine in major depressive disorder (MDD), sponsored by Eli Lilly and Company. Started Mar 2010; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01070329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01070329.